Company profile

STIMIT AG

Mechanical ventilation is life-saving, especially these days. However during mechanical ventilation, natural lung function is suppressed, and the diaphragm (core breathing muscle) becomes inactive and weak. Often too weak for sufficient breathing, so that patients become adapted to and sometimes dependent on mechanical ventilation (weaning required). STIMIT is developing therapy and medical device to empower patients in intensive care to breathe. The startups technology can non-invasively activate the body's own breathing function. The therapy goal is to maintain breathing muscle function during ventilation, to minimize life-threatening damage to the lungs from mechanical ventilation, and shorten the duration of ventilation. Let's treat more ventilated patients in less time.

More news about STIMIT AG

08.04.2025 16:35

Key advancements in the biotech and medtech landscape

Please login or
register to use the
awards follow feature
27.11.2024 16:00

Development milestones to propel Medtechs to next step

Please login or
register to use the
awards follow feature
21.03.2024 12:15

Drei Deeptech-Startups im Finale um den ZKB Pionierpreis Technopark

Please login or
register to use the
awards follow feature
25.01.2024 14:35

ZKB Pionierpreis Technopark shortlists 11 startups

Please login or
register to use the
awards follow feature
26.09.2022 14:33

Preise für Planted und Stimit

Please login or
register to use the
awards follow feature
16.12.2021 16:42

Schneller wieder selbständig atmen

Please login or
register to use the
awards follow feature
06.04.2021 16:49

Exit für STIMIT-Gründer

Please login or
register to use the
awards follow feature
01.04.2020 15:38

STIMIT receives CHF 150K to hasten recovery of ventilated patients

Please login or
register to use the
awards follow feature
STIMIT AG

Founded
2018

Kanton
BE

Homepage

rss